Depression and Anxiety Linked to Lower Antihypertensive Medication Use in Hypertension Patients

How Do Depression and Anxiety Affect Blood Pressure Medication Use?

A descriptive analysis drawing on data from the National Health and Nutrition Examination Survey (NHANES) — a nationally representative survey conducted by the Centers for Disease Control and Prevention — has examined the intersection of mental health and cardiovascular medication adherence. The findings indicate that among adults diagnosed with hypertension, those who also screen positive for depression or anxiety show lower rates of antihypertensive medication use compared to those without mental health comorbidities.

This pattern is clinically significant because uncontrolled hypertension remains a leading risk factor for heart attack, stroke, and kidney disease. According to the American Heart Association, nearly half of American adults have hypertension, and only about one in four have it under control. The added burden of untreated or undertreated mental health conditions may create a compounding cycle where psychological distress undermines the very medication behaviors needed to prevent cardiovascular events.

Why Might Mental Health Conditions Reduce Medication Adherence?

The mechanisms linking mental health conditions to poor medication adherence are well-documented in clinical literature. Depression is associated with fatigue, hopelessness, and reduced motivation — all factors that make it harder to maintain consistent health routines. Anxiety, meanwhile, can lead to avoidance behaviors, including avoidance of the healthcare system itself. Some patients with anxiety may also worry about medication side effects, leading them to skip doses or discontinue treatment without consulting their physician.

Additionally, certain antihypertensive drug classes — particularly beta-blockers and some centrally acting agents — have historically been associated with mood-related side effects, which may further discourage adherence in patients already struggling with mental health. The NHANES analysis adds population-level evidence to what clinicians have long observed at the bedside: managing blood pressure effectively often requires addressing the whole patient, including their psychological well-being.

What Does This Mean for Integrated Hypertension and Mental Health Care?

The findings reinforce growing calls from organizations like the American Heart Association and the World Health Organization for integrated care models that address mental and physical health simultaneously. The WHO has emphasized that depression is a major contributor to the global burden of disease, and its intersection with chronic conditions like hypertension creates particularly high-risk patient populations. Screening tools such as the PHQ-9 for depression and GAD-7 for anxiety are brief, validated, and increasingly used in primary care settings.

From a treatment perspective, collaborative care models — where mental health professionals work alongside primary care physicians — have shown promise in improving outcomes for patients with comorbid conditions. Some antihypertensive medications, such as ACE inhibitors and ARBs, have neutral or potentially favorable effects on mood, making informed drug selection another tool in the clinician's arsenal. The NHANES data underscores that cardiovascular risk management cannot be fully effective when mental health remains unaddressed.